Ambrx Biopharma Inc - ADR

NYSE:AMAM  
13.53
-0.29 (-2.10%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)498.60M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.76 Million
Adjusted EPS-$0.11
See more estimates
10-Day MA$14.91
50-Day MA$17.86
200-Day MAN/A
See more pivots

Ambrx Biopharma Inc - ADR Stock, NYSE:AMAM

10975 North Torrey Pines Road, La Jolla, California 92037
United States of America
Phone: +1.858.875.2400
Number of Employees: 70

Description

Ambrx Biopharma Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA.